|
|
|
|
 |
Arena Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference |
| Companies mentioned in this article: |
|
Arena Pharmaceuticals |
|
| 5/9/2008 @ 6:24 AM
print this article -
email to a friend -
join our eNewsletter
|
 |
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) announced today that the company is scheduled to present at the Bank of America 2008 Healthcare Conference on May 14, 2008 at 5:20 p.m. Pacific Time (8:20 p.m. Eastern Time) at the Four Seasons Hotel in Las Vegas, Nevada. Dominic P. Behan, Ph.D., Arena's Senior Vice President and Chief Scientific Officer, is scheduled to provide an overview of the company, including its clinical development and discovery programs.
A live audio webcast of the presentation will be available under the investor relations section of Arena's website at www.arenapharm.com/. A replay of the presentation will be available until May 30, 2008. Please connect to Arena's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.
About Arena Pharmaceuticals
Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds target G protein-coupled receptors, an important class of validated drug targets, and includes compounds being evaluated independently and with partners, including Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc. |
| BioTech / BioMedical / Medical |
|
|
| |
| Friday, May 16, 2008 |
 |
|
Phenomix Announces PHX1149 Phase 2b Clinical Trial Results for Type 2 Diabetes Posted 3:41 PM PST
ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study Posted 6:15 AM PST
Invitrogen Launches Cell Therapy Business Unit Posted 6:02 AM PST
|
| |
| Thursday, May 15, 2008 |
|
|
CardioDynamics Announces Significant ICG Study with Nearly Three Times the National Average Blood Pressure Control Rates at the American Society for Hypertension Annual Scientific Meeting Posted 8:57 AM PST
|
| |
| Wednesday, May 14, 2008 |
|
|
Ardea Biosciences Announces Upcoming Corporate Meetings Posted 5:32 PM PST
Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute Posted 9:25 AM PST
TorreyPines Therapeutics to Present at the JMP Seventh Annual Securities Conference Posted 9:22 AM PST
PacificGMP Completes GMP Product Fill for Trius Therapeutics Posted 9:18 AM PST
Duska Therapeutics Sponsored University of Pennsylvania Study Demonstrates ATP Improves Sperm Motility and In Vitro Fertilization in Animals Posted 9:17 AM PST
Outsource Manufacturing, Inc., San Diego Contract Manufacturer, Certified to ISO 13485 Posted 8:40 AM PST
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences Posted 8:14 AM PST
International Stem Cell Corporation’s Human Parthenogenetic Stem Cells to be used in the Development of Treatments for Liver Disease Posted 8:13 AM PST
|
| |
| Tuesday, May 13, 2008 |
|
|
ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference Posted 9:37 AM PST
Visage Imaging to Provide Fully Integrated Thin Client-Based Solution to Tufts Medical Center Posted 9:35 AM PST
AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients Posted 9:32 AM PST
Transdel Pharmaceuticals to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference Posted 9:30 AM PST
Lankford Selected to Build New $115 Million Research Facility for San Diego Consortium for Regenerative Medicine Posted 9:03 AM PST
Sequenom to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference Posted 8:54 AM PST
Invitrogen Launches New Animal Origin Free Substrate for Stem Cells Posted 8:52 AM PST
Bio-Matrix Scientific Group, Inc. to Issue Preferred Stock Dividend to Its Shareholders of Record May 28th Posted 8:42 AM PST
|
| |
| Monday, May 12, 2008 |
|
|
Neurocrine Biosciences to Present at the 2008 Citi Investment Research Global Health Care Conference Posted 5:00 PM PST
Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences Posted 4:48 PM PST
Cytori to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference Rodman & Renshaw Global Healthcare Conference 2008 Posted 4:04 PM PST
Novalar Receives FDA Approval for OraVerse Posted 6:18 AM PST
Vical to Present at Upcoming Investor Conferences Posted 6:17 AM PST
Amylin Pharmaceuticals to Present at Baird Growth Stock Conference Posted 6:17 AM PST
Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial Posted 6:12 AM PST
Yale University Purchases Sequenom MassARRAY Platform Posted 6:06 AM PST
Hollis-Eden Pharmaceuticals to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference Posted 6:04 AM PST
|
| |
| Friday, May 9, 2008 |
|
|
Arena Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference Posted 6:24 AM PST
CardioDynamics Shareholders Approve One-for-Seven Reverse Split of Company's Common Stock and Trading in Post-split Shares Begins May 9, 2008 Posted 6:23 AM PST
Gen-Probe to Webcast Two Upcoming Investor Presentations Posted 6:21 AM PST
Cytori Reports First Celution System Revenues During the First Quarter; Provides Update on Celution System Commercialization Posted 6:15 AM PST
|
| |
| Thursday, May 8, 2008 |
|
|
Total Training Selected as the Exclusive In-the-Box Video Training Provider for Microsoft Expression Studio 2 Posted 3:38 PM PST
Arena Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference Posted 3:36 PM PST
Metabasis to Present at the Bank of America 2008 Health Care Conference Posted 3:29 PM PST
Ortho Organizers Introduces New Premium Product Line - O2 Select Orthodontic Instruments Posted 8:36 AM PST
Volcano Corp Announces First Human Use of the Volcano Optical Coherence Tomography (OCT) Imaging Catheter Posted 8:35 AM PST
DR Systems’ Integration of Mammography with PACS to Be Showcased at ACR Meeting Posted 8:05 AM PST
Nvitrogen and WARF Sign License Agreement for Human Embryonic Stem Cells Posted 8:05 AM PST
Bio-Matrix Scientific Group Identifies Near Term Revenue Sources Posted 8:02 AM PST
Aethlon Medical Releases Smallpox Related Research Data Posted 8:00 AM PST
|
| |
| Wednesday, May 7, 2008 |
|
|
Amylin Pharmaceuticals to Present at Bank of America Healthcare Conference Posted 2:18 PM PST
Sequenom Abstract Selected for ‘Blue Ribbon’ Designation for Presentation at ACOG Annual Meeting Posted 6:23 AM PST
Orexigen Therapeutics Announces Completion of Patient Enrollment in Phase III Clinical Program for Contrave Posted 6:23 AM PST
La Jolla Pharmaceutical Company Announces Pricing of Common Stock and Warrant Unit Offering Posted 6:21 AM PST
Invitrogen Scientists Link microRNA Sequences to Cancer Using RNA Samples from BioServe Posted 6:11 AM PST
Bio-Matrix Scientific Group, Inc. Installs Computype’s Secured Blood Bank Labeling and Identification Systems for its Adult Stem Cell Processing and Cryogenic Banking Laboratories Posted 6:09 AM PST
|
| |
| Tuesday, May 6, 2008 |
|
|
Illumina Completes Sequencing of African Trio Posted 8:59 AM PST
Aethlon Hemopurifier Effective in Capturing West Nile Virus Posted 8:59 AM PST
TriLink Awarded a Phase II Grant for a Second Hot Start PCR Project Posted 8:24 AM PST
Halozyme Therapeutics to Present at Upcoming Investor Conferences Posted 8:18 AM PST
NuVasive to Present at Bank of America 2008 Health Care Conference Posted 8:08 AM PST
|
| |
| Monday, May 5, 2008 |
|
|
Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity Posted 4:29 PM PST
Biocept Launches Noninvasive Prenatal Rh(D) Diagnostic at Annual ACOG Scientific Meeting Posted 6:39 AM PST
Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca Posted 6:37 AM PST
Orexigen Therapeutics to Present at Upcoming Investor Conferences Posted 6:32 AM PST
Bio-Matrix Scientific Group, Inc. Submits Application and Quality Systems Documentation to the State of California for Tissue Bank License Posted 6:31 AM PST
Applied Biosystems & Bio-Rad Gain Gene Expression Profiling Market Share Posted 6:02 AM PST
|
|
|
|
|
|
FreshNews.com Jobs Change DAILY
We Have 5.000 + Job Listings! Open Your FREE Account
Employers or Job Searchers Get Started Now! Click Here
|
